The other genes in this study were identified, completely new and more effective therapies lead to manage cholesterol levels and reduce the risk of heart disease. Functions predict the genetic changes if it help if each one is developing high LDL or low HDL.. ‘Each of these genes is a potentially interesting target,’said Abecasis. Statins, a class of cholesterol-lowering medications are used to reduce the risk of heart disease, the HMGCR gene, one of the target genes identified in this study.
The gene, called melatonin receptor helps in the regulation of the circadian clock, among others. The finding strengthens the link between sleep disorders and diabetes, Boehnke said.TITLE: Complementary roles of IRS-1 and IRS-2 in hepatic metabolic regulationAUTHOR CONTACT U.S.: C. Ronald Kahn, Joslin Diabetes Center, Massachusetts, USA Phone: 732-2635 Fax: 732-2593, email:View PDF this item among: the-jci.org/press/23187.pdf – from 05:00 U.S. EST Thursday February 2005 the PDF of this item be:.